Indoco Remedies promoters buy 4,000 shares in open market on Sept 1
- Promoters Aditi M. Panandikar and Madhura Suresh Kare bought 4,000 shares total
- Each promoter acquired 2,000 shares via open market on September 1, 2026
- Combined promoter holding increased from 5.86% to 5.86% (rounded)
- Total equity share capital remains unchanged at ₹18,46,07,210

*this image is generated using AI for illustrative purposes only.
Indoco Remedies promoters Aditi M. Panandikar and Madhura Suresh Kare acquired a combined 4,000 equity shares from the open market on September 1, 2026, as disclosed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Acquisition details
Each promoter acquired 2,000 equity shares, representing 0.002% of the total share and voting capital of Indoco Remedies. The disclosure was filed by Aditi M. Panandikar for herself and on behalf of Madhura Suresh Kare. Both acquirers belong to the promoter group of the company.
Shareholding before and after acquisition
The table below captures the individual and combined holdings of the two promoters before and after the transaction.
| Promoter | Shares before acquisition | % before | Shares acquired | Shares after acquisition | % after |
|---|---|---|---|---|---|
| Aditi M. Panandikar | 29,22,158 | 3.17 | 2,000 | 29,24,158 | 3.17 |
| Madhura Suresh Kare | 24,84,513 | 2.69 | 2,000 | 24,86,513 | 2.69 |
| Combined total | 54,06,671 | 5.86 | 4,000 | 54,10,671 | 5.86 |
Neither promoter holds any shares in the nature of encumbrance, voting rights otherwise than by equity shares, or warrants or convertible securities, either before or after the acquisition.
Company share capital
The equity share capital of Indoco Remedies remains unchanged at ₹18,46,07,210/-, divided into 9,23,03,605 equity shares of ₹2/- each, both before and after the acquisition. The total diluted share and voting capital of the company is likewise unchanged at ₹18,46,07,210/-, divided into 9,23,03,605 equity shares of ₹2/- each.
The shares of Indoco Remedies are listed on BSE Limited and the National Stock Exchange of India Limited.
Historical Stock Returns for Indoco Remedies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.12% | +0.02% | +10.53% | +33.98% | -17.53% | 0.0% |
What strategic rationale might drive Indoco Remedies promoters to accumulate additional equity shares despite their existing significant stake?
How could this open market acquisition signal the promoter group's confidence in Indoco Remedies' near-term financial performance or valuation?
Are there indications that this purchase is part of a broader plan to consolidate control ahead of potential corporate actions or regulatory changes?































